Oculis Holding AG (OCS) Long-Term Investments (2021 - 2025)

Oculis Holding AG (OCS) recorded quarterly Long-Term Investments of $239.1 million in Q4 2025, up 9.61% quarter-over-quarter from $218.1 million in Q4 2024, and up 9.61% on a YoY basis from $218.1 million in Q4 2024.

Oculis Holding AG (OCS) Long-Term Investments (2021 - 2025) Analysis & Trends

Oculis Holding AG's Long-Term Investments history runs 5 years deep, the most recent figure standing at $239.1 million for Q4 2025.

  • In Q4 2025, Long-Term Investments rose 9.61% year-over-year to $239.1 million; the TTM figure through Dec 2025 stood at $239.1 million (up 9.61% YoY), while the FY2025 annual figure was $239.1 million, up 9.61% from the prior year.
  • Long-Term Investments was $239.1 million for Q4 2025 at Oculis Holding AG, up from $218.1 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $239.1 million in Q4 2025 to a low of $51901.1 in Q4 2022.
  • Historically, Long-Term Investments has averaged $134.5 million across 5 years, with a median of $215.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Long-Term Investments fell 7.97% in 2022, then jumped 414920.6% in 2023.
  • A 5-year view of Long-Term Investments shows it stood at $56394.1 in 2021, then slipped by 7.97% to $51901.1 in 2022, then surged by 414920.6% to $215.4 million in 2023, then gained by 1.26% to $218.1 million in 2024, then rose by 9.61% to $239.1 million in 2025.
  • The last three Long-Term Investments figures came in at $239.1 million (Q4 2025), $218.1 million (Q4 2024), and $215.4 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 5.75 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 239.06 Mn
Dec 31, 2024 218.11 Mn
Dec 31, 2023 215.40 Mn
Dec 31, 2022 51,901.10
Dec 31, 2021 56,394.11